Through pooled investigation, it was determined that a correlation exists between elevated serum sCD163 and worse OS (HR = 2.24, 95% CI: 1.50-3.35, <i>P</i> < 0.001) and PFS (HR = 3.90, 95% CI: 2.33-6.52, <i>P</i> < 0.001) among tumor cases. Here, CD163 is linked to neoplasm.